Head Medical oncology @ Narayana Health , Delhi NCR .Director Oncomed Clinic Delhi .
Hauz Khas, New Delhi
Joined April 2020
- Tweets80
- Following27
- Followers119
- Likes33
RANDEEP Singh retweeted
The ethics editorial argues that equitable immunotherapy access in India requires evidence-based use of high-value regimens, low-dose science, indigenous innovation, and policy reforms so that precision oncology and affordability advance together.
ijmio.com/the-ethics-of-immu…
RANDEEP Singh retweeted
The head-and-neck cancer treatment review finds that both neoadjuvant chemo followed by surgery and definitiveCRT are curative options, with CRT remaining the mainstay while neoadjuvant chemotherapy is particularly valuable for downstaging prior to Sx
ijmio.com/neoadjuvant-chemot…
RANDEEP Singh retweeted
The immune checkpoint inhibitor review concludes that ICIs have reshaped outcomes in recurrent/metastatic HNSCC offering durable responses for a subset of patients but demanding biomarker-driven selection to overcome resistance, &financial burden
ijmio.com/emerging-role-of-i…
RANDEEP Singh retweeted
New in IJMIO: An editorial on the ethics of immunotherapy access, Review on immune checkpoint inhibitors in recurrent/metastatic H&N SCC, a comparative review of neoadjuvant chemo plus surgery vS definitive chemoradiotherapy in locally advanced head-and-neck cancer—now online
The September-December 2025 issue of International Journal of Molecular and Immuno Oncology. Published by @scientifscholar on behalf of Alms Tech LLP. ijmio.com/issue/2025-10-3
@IjmioJournal #ScientificScholar #IJMIO #MolecularOncology #ImmunoOncology #CancerResearch
RANDEEP Singh retweeted
Dear Colleagues
Coming 1⃣st Week of February 2026:
The 6th Annual OncoAlert Colloquium 🚨
REGISTER👉 buff.ly/UDfpkP8
Our Faculty List Keeps on Growing and
As ALWAYS ✅Patients Included
#BreastCancer
@hoperugo🇺🇸
@matteolambe🇮🇹
@Icro_Meattini🇮🇹
Dr. Roberto Salgado 🇧🇪
@ErikaHamilton9 🇺🇸
@DrSGraff 🇺🇸
@E_de_Azambuja 🇧🇪
@itrisabel🇪🇸 ESSO
@ElisaAgostinett 🇧🇪
Dr. Fatima Cardoso 🇵🇹 @ABCGlobalAll
@LazarPo31787807 🇷🇸
#LungCancer
@GlopesMd🇺🇸
@jillfeldman4 @EGFRResisters🇺🇸
@UmbertoMalapel1 🇮🇹 @isliquidbiopsy
@BRicciutiMD 🇺🇸
@UOzkerim 🇹🇷
GU Oncology
@brian_rini @Uromigos🇺🇸
@declangmurphy @gu_onc🇦🇺
@KidneyCancer🇺🇸
@APCCC_Lugano🇨🇭
@RenuEapen🇦🇺
@nataliagandur 🇦🇷
@seanmcbride 🇺🇸
GI Oncology
@BenWestphalen 🇩🇪
@CathyEngMD 🇺🇸
@florianlordick 🇩🇪
@NiuSanford 🇺🇸
@realbowtiedoc 🇺🇸
@ARosen380 🇺🇸
@Erman_Akkus 🇹🇷
Melanoma
@DrBetofMDPhD 🇺🇸
Our Partners
@ESGO_society @ESSOnews @CancerCareMASCC @SIOGorg
Our Collaborators
APCCC, GU CAST, @Uromigos and more
and more to come.......
#OncoAlertAF
@HHorinouchi @FernandoOnco
@ElisaAgostinett @to_be_elizabeth @GaiaGriguolo @MarioBalsaMD @DrMirallas @GIMedOnc @DrRishabhOnco @Onco_Cifu88 @PaulJiL
RANDEEP Singh retweeted
🚨 New Issue Alert!
The International Journal of Molecular and Immuno Oncology (IJMIO) Volume 10, Issue 2 (May–Aug 2025) is now published online. Explore cutting-edge work in molecular oncology, immunotherapy, and translational research: ijmio.com/issue/2025-10-2/
RANDEEP Singh retweeted
"Exciting progress in cancer care in India”@Prasshmehta & @QuantumOnc highlight key steps in the right direction to improve treatment and access.
A must-read for anyone following advancements in cancer
#CancerCare #India #HealthcareInnovation #Oncology
ijmio.com/transforming-cance…
RANDEEP Singh retweeted
This is an important milestone, ensuring the journal is aligned with the standards required for academic credibility.
The EMBASE coverage will start from Janउआर्य 2025 onward, ensuring that all articles published from this date will be available in the database @QuantumOnc
RANDEEP Singh retweeted
Hey Sheetal nice thread on the checkpoints to watch for when markets are at ATH.👍
The explanation with charts especially BO /BD with retest is really useful. 👌
Awesome thread 👏
RANDEEP Singh retweeted
Phase III Randomized Trial for Use of Docetaxel in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation. @VanitaNoronha @Amolpatel_dr @Nandinimenon18 @DrEzraCohen @JCO_ASCO @HHKhar @TataMemorial @DrHaddadRobert ascopubs.org/doi/abs/10.1200…
RANDEEP Singh retweeted
Please read the Ahead of Print articles published by IJMIO at @OncomedR @purvish1 @DrRadhikaV @scientifscholar
ijmio.com/articles/ahead-of-…
RANDEEP Singh retweeted
Inauguration of chemotherapy day care@Borivali . This day care is supported by Tata hospital and Nana palkar Smruti Samiti . And sunrise oncology team will look after the patient care services.@tmhmedoncalumni
RANDEEP Singh retweeted
On auspicious occasion of Navaratri important MOU between TMH and Nana Palkar Smruti Samiti.Cancer patients will get benefited in western suburbs of Mumbai with starting 1st chemo day care in collaboration with Sunrise Onco centre Borivali.@TataMemorial
RANDEEP Singh retweeted
Interview by Dr Shweta Bansal with Dr Sholler, who is PI for advanced therapies and DFMO drug in HR Neuroblastoma
youtube.com/watch?v=6fP1NPkZ… @IjmioJournal @OncomedR @DrRadhikaV @purvish1
RANDEEP Singh retweeted
📖 Our multi-centre study:
2 drug vs 3 drug induction in pediatric acute myeloid leukemia
nature.com/articles/s41408-0…
✅ No benefit in survival with addition of 3rd drug etoposide (ADE) to dauno and ARAC (3+7)
✅ Similar toxicities
✅ First INPHOG RCT
✅ First RCT on AML from LMIC
RANDEEP Singh retweeted
More than Supreme court. It is our colleagues who need to be convinced. Unfortunately many of us forget that NCCN guidelines are made with USA in focus and not the Globe.
RANDEEP Singh retweeted
ImmunoACT CAR-T Facility at Rabale Navi Mumbai . @DrVijayPatil11 @ActImmuno @purwarrahul2 @SunriseOncoCare
RANDEEP Singh retweeted
Please watch the latest video release by International Journal of Molecular and Immuno Oncology (Ijmio Ijmio)
Meet the team: A video by executive editor, Dr. Radhika Vaishnav
youtube.com/watch?v=ZMHnB6YL… @IjmioJournal @OncomedR @DrRadhikaV @purvish1
